Literature DB >> 18482721

Origins and virulence mechanisms of uropathogenic Escherichia coli.

Travis J Wiles1, Richard R Kulesus, Matthew A Mulvey.   

Abstract

Strains of uropathogenic E. coli (UPEC) are the primary cause of urinary tract infections, including both cystitis and pyelonephritis. These bacteria have evolved a multitude of virulence factors and strategies that facilitate bacterial growth and persistence within the adverse settings of the host urinary tract. Expression of adhesive organelles like type 1 and P pili allow UPEC to bind and invade host cells and tissues within the urinary tract while expression of iron-chelating factors (siderophores) enable UPEC to pilfer host iron stores. Deployment of an array of toxins, including hemolysin and cytotoxic necrotizing factor 1, provide UPEC with the means to inflict extensive tissue damage, facilitating bacterial dissemination as well as releasing host nutrients and disabling immune effector cells. These toxins also have the capacity to modulate, in more subtle ways, host signaling pathways affecting myriad processes, including inflammatory responses, host cell survival, and cytoskeletal dynamics. Here, we discuss the mechanisms by which these and other virulence factors promote UPEC survival and growth within the urinary tract. Comparisons are also made between UPEC and other strains of extraintestinal pathogenic E. coli that, although closely related to UPEC, are distinct in their abilities to colonize the host and cause disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18482721      PMCID: PMC2595135          DOI: 10.1016/j.yexmp.2008.03.007

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  115 in total

1.  Uropathogenic Escherichia coli flagella aid in efficient urinary tract colonization.

Authors:  Kelly J Wright; Patrick C Seed; Scott J Hultgren
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

Review 2.  Pathogenicity islands: a molecular toolbox for bacterial virulence.

Authors:  Ohad Gal-Mor; B Brett Finlay
Journal:  Cell Microbiol       Date:  2006-08-24       Impact factor: 3.715

3.  Role of the lipopolysaccharide-CD14 complex for the activity of hemolysin from uropathogenic Escherichia coli.

Authors:  Lisa E Månsson; Peter Kjäll; Shahaireen Pellett; Gábor Nagy; Rodney A Welch; Fredrik Bäckhed; Teresa Frisan; Agneta Richter-Dahlfors
Journal:  Infect Immun       Date:  2006-11-13       Impact factor: 3.441

4.  Inactivation of host Akt/protein kinase B signaling by bacterial pore-forming toxins.

Authors:  Travis J Wiles; Bijaya K Dhakal; Danelle S Eto; Matthew A Mulvey
Journal:  Mol Biol Cell       Date:  2008-01-30       Impact factor: 4.138

5.  Escherichia coli K1's capsule is a barrier to bacteriophage T7.

Authors:  Dean Scholl; Sankar Adhya; Carl Merril
Journal:  Appl Environ Microbiol       Date:  2005-08       Impact factor: 4.792

6.  Calcium is required for binding of Escherichia coli hemolysin (HlyA) to erythrocyte membranes.

Authors:  D F Boehm; R A Welch; I S Snyder
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

7.  Comparison of Escherichia coli isolates implicated in human urinary tract infection and avian colibacillosis.

Authors:  Kylie E Rodriguez-Siek; Catherine W Giddings; Curt Doetkott; Timothy J Johnson; Mohamed K Fakhr; Lisa K Nolan
Journal:  Microbiology       Date:  2005-06       Impact factor: 2.777

8.  Role of Escherichia coli K capsular antigens during complement activation, C3 fixation, and opsonization.

Authors:  W C Van Dijk; H A Verbrugh; M E van der Tol; R Peters; J Verhoef
Journal:  Infect Immun       Date:  1979-08       Impact factor: 3.441

9.  Effect of Escherichia coli alpha-hemolysin on human peripheral leukocyte function in vitro.

Authors:  S J Cavalieri; I S Snyder
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

Review 10.  Pathogenic Escherichia coli.

Authors:  James B Kaper; James P Nataro; Harry L Mobley
Journal:  Nat Rev Microbiol       Date:  2004-02       Impact factor: 60.633

View more
  187 in total

1.  Distinguishing the contribution of type 1 pili from that of other QseB-misregulated factors when QseC is absent during urinary tract infection.

Authors:  Maria Kostakioti; Maria Hadjifrangiskou; Corinne K Cusumano; Thomas J Hannan; James W Janetka; Scott J Hultgren
Journal:  Infect Immun       Date:  2012-06-04       Impact factor: 3.441

2.  Decreased expression of type 1 fimbriae by a pst mutant of uropathogenic Escherichia coli reduces urinary tract infection.

Authors:  Sébastien Crépin; Sébastien Houle; Marie-Ève Charbonneau; Michaël Mourez; Josée Harel; Charles M Dozois
Journal:  Infect Immun       Date:  2012-06-04       Impact factor: 3.441

3.  Molecular characterization of UpaB and UpaC, two new autotransporter proteins of uropathogenic Escherichia coli CFT073.

Authors:  Luke P Allsopp; Christophe Beloin; Glen C Ulett; Jaione Valle; Makrina Totsika; Orla Sherlock; Jean-Marc Ghigo; Mark A Schembri
Journal:  Infect Immun       Date:  2011-09-19       Impact factor: 3.441

Review 4.  [Virulence factors of uropathogens].

Authors:  U Dobrindt
Journal:  Urologe A       Date:  2010-05       Impact factor: 0.639

5.  Ag43 promotes persistence of uropathogenic Escherichia coli isolates in the urinary tract.

Authors:  Petra Lüthje; Annelie Brauner
Journal:  J Clin Microbiol       Date:  2010-03-31       Impact factor: 5.948

6.  Similarity and divergence of phylogenies, antimicrobial susceptibilities, and virulence factor profiles of Escherichia coli isolates causing recurrent urinary tract infections that persist or result from reinfection.

Authors:  Yanping Luo; Yanning Ma; Qiang Zhao; Leili Wang; Ling Guo; Liyan Ye; Youjiang Zhang; Jiyong Yang
Journal:  J Clin Microbiol       Date:  2012-10-03       Impact factor: 5.948

7.  Transcriptional responses of uropathogenic Escherichia coli to increased environmental osmolality caused by salt or urea.

Authors:  Benjamin Withman; Thusitha S Gunasekera; Pavani Beesetty; Richard Agans; Oleg Paliy
Journal:  Infect Immun       Date:  2012-10-22       Impact factor: 3.441

8.  Inactivation of Transcriptional Regulators during Within-Household Evolution of Escherichia coli.

Authors:  Dagmara I Kisiela; Matthew Radey; Sandip Paul; Stephen Porter; Kseniya Polukhina; Veronika Tchesnokova; Sofiya Shevchenko; Diana Chan; Maliha Aziz; Timothy J Johnson; Lance B Price; James R Johnson; Evgeni V Sokurenko
Journal:  J Bacteriol       Date:  2017-06-13       Impact factor: 3.490

9.  Molecular Characterization of Uropathogenic Escherichia coli: Nalidixic Acid and Ciprofloxacin Resistance, Virulent Factors and Phylogenetic Background.

Authors:  Shreya Basu; Sandip Kumar Mukherjee; Avijit Hazra; Mandira Mukherjee
Journal:  J Clin Diagn Res       Date:  2013-12-15

10.  Host-specific induction of Escherichia coli fitness genes during human urinary tract infection.

Authors:  Sargurunathan Subashchandrabose; Tracy H Hazen; Ariel R Brumbaugh; Stephanie D Himpsl; Sara N Smith; Robert D Ernst; David A Rasko; Harry L T Mobley
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.